J&J profits up amid drug gains
January 23, 2014Sales and Marketing FDA, J&J, JJ, Remicade, Zytiga, olysio, q4
Johnson & Johnson’s sales in the fourth quarter of 2013 rose 4.5% compared to the same period in the previous …
ABPI: NHS must explain drugs take-up
January 22, 2014Sales and Marketing ABPI, NHS, NICE, Whitehead
The ABPI has called on the NHS to explain what it says is the ‘substantial variation’ in NHS patients’ access …
J&J tops social media leaderboard
January 22, 2014Medical Communications, Research and Development, Sales and Marketing Facebook, IMS, J&J, JJ, Twitter, You Tube, social media
A new report has found that Johnson & Johnson is the most engaged pharma company when it comes to using …
Director appointments at Hanover
January 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, harrison
Comms and PR consulting firm Hanover has announced senior management changes within its healthcare practice. Andrew Harrison (pictured) takes on …
NICE recommends Aubagio
January 22, 2014Sales and Marketing Aubagio, EU, FDA, NICE, Sanofi, gilenya
NICE has recommended Genzyme’s multiple sclerosis pill Aubagio for use on the NHS. In final guidance the watchdog said Aubagio …
EU regulator recommended 81 medicines in 2013
January 21, 2014CHMP, EC, EU, FDA, US, rare diseases
Last year the Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for marketing approval, compared with just …
Emergent plans to triple anthrax vaccine production
January 21, 2014Manufacturing and Production Emergent BioSolutions, FDA, anthrax, biothrax
Emergent BioSolutions is planning a major expansion of manufacturing capacity for its anthrax vaccine BioThrax to meet the biodefense objectives …
Herceptin biosimilar set for Indian market
January 21, 2014Research and Development, Sales and Marketing Biocon, Herceptin, Roche, biosimilars, canmab
Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …
AbbVie advances oncology drug
January 21, 2014Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib
AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer. This …
Roche schizophrenia drug fails
January 21, 2014Research and Development, Sales and Marketing Roche, biopertin, schizophrenia
Roche’s investigational schizophrenia drug bitopertin has failed to help patients with the disorder’s negative symptoms when pitted against placebo. Two …
Manufacturing news in brief
January 21, 2014Manufacturing and Production BASF, Heidelberg CSAT, Markem-Imaje, SEPIPROD and Micro-Sphere/NanoMaterials Technology, SPL, Shenzhen Hepalink
Shenzhen Hepalink buys SPL and Markem-Imaje takes over Heidelberg CSAT, plus a new science park in the UK and updates …
Novasep adds president to complete its executive team
January 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nieuwenhove, Novasep
Thierry Van Nieuwenhove has joined contract manufacturing organisation Novasep as president of its Synthesis business unit. Educated as a bio-engineer, Van …
Actavis makes Aurobindo sale
January 21, 2014Sales and Marketing Actavis, Aurobindo, India, generics
Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …
Government sugar tsar works for Coca-Cola and Mars
January 20, 2014Sales and Marketing UK government, action on sugar, macdonald
It has been revealed that the man tasked by the UK government to help implement tougher regulation on sugar levels …
Ranbaxy quality issues hit sixth plant; seeks Diovan workaround
January 20, 2014Manufacturing and Production FDA, Ranbaxy, fines, manufacturing
Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …
Merck recalls Liptruzet on packaging defects
January 20, 2014Manufacturing and Production FDA, Merck, US, liptruzet, recall
Merck & Co has been forced to undertake a massive recall of its combination cholesterol-lowering drug Liptruzet in the US …
J&J to sell division for $4.1 billion
January 20, 2014Sales and Marketing Diagnostics, J&J, JJ, carlyle, ocd, ortho-clinical
Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …
Shire sheds Dermagraft at $650m loss
January 20, 2014Sales and Marketing Organogenesis, Shire, dermagraft
Shire has offloaded its Dermagraft business to Organogenesis just three years after purchasing the company. Given the sale has come …
Problems and solutions
January 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing adams, culture, pharma, problems, social media
Not long ago I was asked to be involved in a project that filmed UK-based pharma journalists in order to …
New chair for British Generic Manufacturers Association
January 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bgma, thomas broeer
Thomas Broeer has been elected as chair of 





The British Generic Manufacturers Association (BGMA). Broeer, managing director of Kent Pharmaceuticals, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
